Dyne Therapeutics, Inc.
SEC CIK 1818794 · DYN · last insider filing 2026-06-30
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Rhodes Jason P | Director | filed 2020 - 2026 |
| Kersten Dirk | Director | filed 2020 - 2026 |
| Greene Barry E | Director | filed 2026 - 2026 |
| Cox John | Director · See Remarks | filed 2024 - 2026 |
| Hurwitz Edward | Director | filed 2020 - 2026 |
| Posner Brian S | Director | filed 2025 - 2026 |
| Lubner David Charles | Director | filed 2020 - 2026 |
| Stehman-Breen Catherine | Director | filed 2020 - 2026 |
| Incerti Carlo | Director | filed 2022 - 2026 |
| Karnani Vikram | Director | filed 2025 - 2025 |
| Brumm Joshua T | Director · See Remarks | filed 2020 - 2024 |
| Klein Lawrence Otto | Director | filed 2020 - 2022 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Lucera Erick | Chief Financial Officer | filed 2025 - 2026 |
| Kerr Douglas | Chief Medical Officer | filed 2024 - 2026 |
| Friedl-Naderer Johanna | Chief Commercial Officer | filed 2024 - 2026 |
| Scalzo Richard William | See Remarks | filed 2020 - 2025 |
| Beskrovnaya Oxana | See Remarks | filed 2020 - 2025 |
| High Susanna Gatti | Chief Operating Officer | filed 2020 - 2024 |
| Mcneill Jonathan | See Remarks | filed 2020 - 2024 |
| Farwell Wildon | Chief Medical Officer | filed 2021 - 2024 |
| Subramanian Romesh | Chief Scientific Officer | filed 2020 - 2020 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.